Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S7BQ
|
||||
Former ID |
DNCL003585
|
||||
Drug Name |
GSK1322322
|
||||
Synonyms |
GSK-1322322
|
||||
Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Phase 2 | [532938] | ||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Peptide deformylase | Target Info | Modulator | [532261], [532938] | |
References | |||||
Ref 532261 | Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322. Antimicrob Agents Chemother. 2013 May;57(5):2333-42. | ||||
Ref 532938 | Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery. Curr Med Chem. 2015;22(2):214-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.